NICOLE JONES-OJO: Open Payments
NPI 1073151577 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$433 in 21 payments from 13 companies in 2025. Trend: 2023 $101 · 2024 $494 · 2025 $433
Food & beverage: $433
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 5 | $109 |
| Fresenius USA Marketing, Inc. | 3 | $59 |
| Travere Therapeutics, Inc. | 2 | $51 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
| ANI Pharmaceuticals, Inc. | 1 | $27 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| Ascendis Pharma Endocrinology Inc | 1 | $22 |
| KYOWA KIRIN, INC. | 1 | $20 |
| AKEBIA THERAPEUTICS INC | 1 | $19 |
| Amgen Inc. | 1 | $19 |
Products named: IBSRELA, VELPHORO, Kerendia, PURIFIED CORTROPHIN GEL, FARXIGA, Yorvipath, CRYSVITA, Vafseo.
Industry payments across VA — which companies pay providers there.
